Efficacy of PBSC mobilization after salvage chemotherapy for relapsed or refractory Hodgkin lymphoma
| Regimen . | n . | % CD34 ≥ 2 × 106/kg . | % CD34 ≥ 5 × 106/kg . | % undergoing marrow harvest . |
|---|---|---|---|---|
| GDP37 | 34 | 97 | 97 | 3 |
| MB37 | 34 | 82 | 57 | 18 |
| ICE21 | 65 | 86 | 67 | 14 |
| Regimen . | n . | % CD34 ≥ 2 × 106/kg . | % CD34 ≥ 5 × 106/kg . | % undergoing marrow harvest . |
|---|---|---|---|---|
| GDP37 | 34 | 97 | 97 | 3 |
| MB37 | 34 | 82 | 57 | 18 |
| ICE21 | 65 | 86 | 67 | 14 |
GDP indicates gemcitabine, dexamethasone, cisplatin; ICE, ifosfamide, carboplatin, etoposide; MB, mini-BEAM; and PBSC, peripheral blood stem cell.